UPDATE : Monday, September 24, 2018
상단여백
DongA unveils new foot fungus treatment
DongA Pharmaceutical said Friday that it has launched Trbinew Once, an easy...
by Lee Han-soo  |  2018-08-24 14:34
라인
Gilead’s Genvoya comfortably tops HIV treatments
Gilead Sciences Korea’s Genvoya has solidified its No. 1 status in the huma...
by Nam Doo-hyun  |  2018-08-24 14:33
라인
Roche Diagnostics donates ₩15 mil. to prevent child abuse
Roche Diagnostics Korea CEO Richard Yiu (left) and Korea Association for Pr...
by Marian Chu  |  2018-08-24 12:10
라인
81% of N. Korean defectors have tuberculosis
A report by the South Korean government’s settlement center for North Korea...
by Lee Min-ju  |  2018-08-24 12:10
라인
Hana Pharm performs P3 tests for new anesthetic agent
Hana Pharm said Thursday that it is conducting phase 3 trials for a new sed...
by Marian Chu  |  2018-08-23 17:31
라인
Boryung launches rapid influenza diagnostic kit
Flu Fast Boryung BioPharm said Thursday it launched its rapid diagnostic ...
by Marian Chu  |  2018-08-23 16:46
라인
Online pictures, videos on suicide, self-harm spiked 3,728% in 2018
Posts related to suicide and self-harm have risen 3,828 percent this year. ...
by Marian Chu  |  2018-08-23 15:12
라인
Ildong, Sandoz to ally in Asia-Pacific
Ildong Pharmaceutical said Thursday that it would enter a strategic allianc...
by Marian Chu  |  2018-08-23 15:11
라인
Myungmoon Pharm’s valsartan additionally suspended
The government said it has completed testing all valsartan-using hypertensi...
by Lee Hye-seon  |  2018-08-23 15:10
라인
Ulsan University Hospital professors find acute leukemia therapy candidate
Korean researchers have found a new drug candidate that maximizes the effec...
by Marian Chu  |  2018-08-23 15:09
라인
3 multinationals refuse to take pharma group’s anti-corruption system
GSK Korea, Janssen Korea and Astellas Pharma Korea refused to adopt ISO 370...
by Nam Doo-hyun  |  2018-08-23 12:01
라인
Dong-A ST, Takara Bio signs licensing agreement for oncolytic virus therapy
Dong-A ST said Thursday it signed a development and sales licensing agreeme...
by Marian Chu  |  2018-08-23 11:49
라인
Bridge Biotherapeutics presents preclinical trial results on ATX inhibitor
Bridge Biotherapeutics, also known as BridgeBio, said Thursday it presented...
by Marian Chu  |  2018-08-23 10:31
라인
5 Korean biopharmaceuticals most active in P3 trials in 5 years
More and more Korean pharmaceuticals are jumping into developing new drugs,...
by Marian Chu  |  2018-08-23 10:31
라인
Boramae Hospital develops new method that can detect Parkinson’s
Researchers at Seoul National University Boramae Hospital demonstrated for ...
by Lee Han-soo  |  2018-08-22 15:03
라인
‘N. Korean defectors’ flu vaccination low due to poor health literacy’
North Korean defectors living in South Korea have low levels of influenza v...
by Choi Gwang-seok  |  2018-08-22 14:59
라인
Foreign CEOs to lead Korean units of Novartis, Galderma
Novartis Korea and Galderma Korea will have new foreign CEOs next month.Nov...
by Nam Doo-hyun  |  2018-08-22 13:56
라인
Boehringer Ingelheim to present sub-analyses on Pradaxa at ESC Congress 2018
Boehringer Ingelheim Korea said Wednesday it would present nine sub-analyse...
by Marian Chu  |  2018-08-22 12:31
라인
Merck to globally distribute T&R Biofab’s bio-ink
T&R Biofab said Wednesday that it has signed an original equipment manufact...
by Lee Han-soo  |  2018-08-22 12:30
라인
Lixiana faces patent challenge in substance, composition
Daiichi Sankyo’s anticoagulant treatment Lixiana (ingredient: edoxaban) has...
by Lee Hye-seon  |  2018-08-22 11:16
여백
여백
여백
Back to Top